Major structural alterations of the c-sis gene are not observed in a series of tumors of the human central nervous system

J Neurooncol. 1989 Nov;7(4):345-56. doi: 10.1007/BF02147092.

Abstract

Expression of the c-sis oncogene, the gene encoding the B chain of platelet-derived growth factor (PDGF), may be related to initiation and/or progression of glial cell tumorigenesis by PDGF-mediated autocrine growth stimulation. As the mechanism for activation of expression of the c-sis gene in gliomas is not known, we searched for possible structural alterations of c-sis DNA in these tumors. Genomic Southern blots of DNA from 7 different cultured human glioblastoma cell lines and 15 different solid human brain tumors revealed no significant change in either the gross structure or the copy number of the c-sis gene in tumor cells vs. control cells. Activation of glioma c-sis gene expression is therefore not the result of a gross rearrangement or amplification of the c-sis gene. Expression of c-sis mRNA was detected in all of 12 different solid human brain tumors, 11 of which were of glial cell origin. However, in tissue adjacent to 5 different tumors, approximately the same level of c-sis mRNA was seen.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Brain Neoplasms / genetics*
  • Brain Neoplasms / metabolism
  • Cell Line
  • Child
  • DNA, Neoplasm / analysis*
  • Female
  • Glioma / genetics*
  • Glioma / metabolism
  • Humans
  • Male
  • Middle Aged
  • Oncogene Proteins v-sis
  • Platelet-Derived Growth Factor / genetics*
  • Platelet-Derived Growth Factor / metabolism
  • Retroviridae Proteins, Oncogenic / genetics*

Substances

  • DNA, Neoplasm
  • Oncogene Proteins v-sis
  • Platelet-Derived Growth Factor
  • Retroviridae Proteins, Oncogenic